bioRxiv Science⌕ Search

Biology subjects

Wu, C.-i.

Publications and source records attributed to Wu, C.-i..

2 recordsLinked to original sources

ADAPTIVE MULTI-SCALE GRAPH TRANSFORMER FRAMEWORK FORHISTOPATHOLOGICAL IMAGES

Whole slide images (WSIs) contain hierarchical information from cellular to tissue architecture but their gigapixel scale poses major memory and computational challenges. Existing multi-scale graph and transformer models capture complex WSI features effectively but struggle with efficiency. We propose an Adaptive Multi-Scale Graph Transformer (AMGT) for WSI classification that addresses this limitation through two key modules: a Self-Guided Token Aggregation (SGTA) mechanism that fuses multi-resolution features to reduce redundancy, and a Prototypical Transformer (PT) that groups similar tokens into phenotype-representative prototypes with linear complexity. This design preserves essential spatial and semantic information, substantially lowering memory cost and improving interpretability by prototypical learning. AMGT achieves superior performance and efficiency, outperforming state-of-the-art models by 1.8% and 5.3% AUC on high-grade ovarian cancer and Camelyon16 datasets, respectively. These results demonstrate AMGTs capacity for scalable, interpretable multi-scale representation learning.

bioinformatics↗

HRDPath: An Explainable Multi-Model Deep Learning Architecture for Predicting Homologous Recombination Deficiency from Histopathology Images

Homologous recombination deficiency (HRD) is a critical biomarker for guiding treatment decisions in high-grade serous tubo-ovarian carcinoma (HGSOC), a cancer with few reliable biomarkers. However, existing genomic-based tests for HRD are variable, expensive, and time-consuming. To this end, we developed HRDPath, a novel patient-level deep learning architecture that combines the strengths of two complementary models with a multi-task design, to predict genomically derived HRD status from whole slide images in HGSOC. HRDPath was comprehensively validated across three datasets and benchmarked against leading deep learning models. It achieved an AUC of 0.846, surpassing previously reported H&E-based HRD prediction results for HGSOC images by 0.09, and for the first time, reporting a specificity of 0.938, where accuracy significantly increased when multiple slides per patient were used. Our proposed patient-level approach and interpretability pipeline enhance model trustworthiness and reveal important clinical and biological insights into HRD-positive cancers, highlighting the associated morphological and pathological changes at the cellular and tissue levels. HRDPath is a potentially accessible and scalable digital biomarker that could improve ovarian cancer diagnosis and therapy selection.

bioinformatics↗